For all sets of analyses that are considered in the exploratory nature and involve testing multiple biomarkers at the same time, the Benjamini-Hochberg procedure will be implemented to calculate adjusted p-value. The adjusted p-value will be calculated per set of analyses, which correspond to each of the endpoints in the objectives. FDR will be controlled at no greater than **10%** for each set of analyses.